Abstract
Bladder cancer is the fourth and ninth most common malignancy in males and females, respectively, in the U.S. and one of the most costly cancers to manage. With the current economic condition, physicians will need to become more aware of cost-effective therapies for the treatment of various malignancies. Robot-assisted radical cystectomy (RARC) is the latest minimally invasive surgical option for muscle-invasive bladder cancer. Current reports have shown less blood loss, a shorter hospital stay, and a lower morbidity with RARC, as compared with the traditional open radical cystectomy (ORC), although long-term oncologic results of RARC are still maturing. There are few studies that have assessed the cost outcomes of RARC as compared with ORC. Currently, ORC appears to offer a direct cost advantage due to the high purchase and maintenance cost of the robotic platform, although when the indirect costs of complications and extended hospital stay with ORC are considered, RARC may be less expensive than the traditional open procedure. In order to accurately evaluate the cost effectiveness of RARC versus ORC, prospective randomized trials between the two surgical techniques with long-term oncologic efficacy are needed.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sievert KD, Amend B, Nagele U, et al. Economic aspects of bladder cancer: what are the benefits and costs? World J Urol. 2009;27:295–300.
Stein JP, Lieskovsky G, Cote R, et al. Radical Cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–75.
Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55:164–76.
Pruthi RS, Nielsen ME, Nix J, et al. Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases. J Urol. 2010;183:510–4.
Wang GJ, Barocas DA, Raman JD, et al. Robotic vs. open radical cystectomy: prospective comparison of perioperative outcomes and pathologic measures of early oncologic efficacy. BJU Int. 2007;101:89–93.
Ng CK, Kauffman EC, Lee MM, et al. A comparison of postoperative complications in open vs. robotic cystectomy. Eur Urol. 2010;57:274–81.
Martin AD, Nunez RN, Pacelli A, et al. Robot-assisted radical cystectomy: intermediate survival results at a mean follow-up of 25 months. BJU Int. 2009;105:1706–9.
Mmeje CO, Nunez-Nateras, R, Nielsen ME, et al. Oncologic Outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cytectomy: with mean follow-up of 3.5 years. Urol Oncol. 2012; Epub
Russell LB, Gold MR, Siegel JE, et al. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996;276:1172–7.
• Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253–8. Recommendations on effective performance of cost-effective analysis.
• Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med. 1990;113:147–54. Great overview of cost-effective analysis.
Eisenberg JM. A guide to the economic analysis of clinical practices. JAMA. 1989;262(20):2879–86.
•• Smith A, Kurpad R, Lal A, et al. Cost analysis of robotic versus open radical cystectomy for bladder cancer. J Urol. 2010;183:505–9. First cost-analysis between open radical cystectomy and robot assisted radical cystectomy.
•• Martin AD, Nunez RN, Castle EP. Robot-assisted radical cystectomy versus open radical cystectomy: a complete cost analysis. Urology. 2011;77:621–5. Cost-analysis between open radical cystectomy and robot assisted radical cystectomy; includes both direct cost and indirect cost of 30-day complications and hospital medications.
•• Lee R, Ng CK, Shariat SF, et al. The economics of robotic cystectomy: cost comparison of open versus robotic. BJU Int. 2011;108:1886–92. Largest cost comparison between open radical cystectomy and robot assisted radical cystectomy. Patients were also stratified by form of urinary diversion.
• Yu H, Hevelone ND, Lipsitz SR, et al. Comparative analysis of outcomes and cost following open radical cystectomy versus robot assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Eur Urol. 2012;61:1239–44. Population based comparison of outcomes between open radical cystectomy and robot assisted radical cystectomy, which also includes comparison of cost.
Pruthi RS, Wallen EM. Robotic-assisted laparoscopic radical cystoprostatectomy. Eur Urol. 2008;53:310–22.
Lotan Y, Cadeddu JA, Gettman MT. The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques. J Urol. 2004;172:1431–5.
Scales Jr CD, Jones PJ, Eisenstein EL, et al. Local cost structures and the economics of robot assisted radical prostatectomy. J Urol. 2005;174:2323–9.
Haber GP, Crouzet S, Gill IS, et al. Laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis. Eur Urol. 2008;54:54–64.
Pruthi RS, Wallen EM. Robotic assisted laparoscopic radical cystoprostatectomy: operative and pathological outcomes. J Urol. 2007;178:814–8.
Hemal AK, Kolla SB, Wadhwa P. First case series of robotic radical cystoprostatectomy, bilateral pelvic lymphadenectomy and urinary diversion with da Vinci-S system. J Robotic Surg. 2008;2:35–40.
Guru KA, Kim HL, Piacente PM, et al. Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer Institute. Urology. 2007;69:469–74.
Pruthi RS, Stefaniak H, Hubbard JS, et al. Robotic assisted anterior exenteration for bladder cancer in female patient. J Endourol. 2008;22:2397–402.
Murphy DG, Challacombe BJ, Elhage O, et al. Robotic-assisted laparoscopic radical cytectomy with extracorporeal urinary diversion: initial experience. Eur Urol. 2008;54:570–80.
Abraham JB, Young JL, Box GN, et al. Comparative analysis of laparoscopic and robot-assisted radical cystectomy with ileal conduit urinary diversion. J Endourol. 2007;21:1473–80.
Novara G, De Marco V, Aragona M, et al. Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol. 2009;182:914–21.
Monoharan M, Ayyathurai R, Soloway MS. Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome. BJU Int. 2009;104:1227–32.
Konety BR, Allareddy V. Influence of post-cystectomy complications on cost and subsequent outcome. J Urol. 2007;177:280–7.
Chang SS, Baumgartner RG, Wells N, et al. Causes of increased hospital stay after radical cystectomy in a clinical pathway setting. J Urol. 2002;167:208–11.
Barbieri CE, Lee B, Cookson MS, et al. Association of procedure volume with radical cystectomy outcomes in a nationwide database. J Urol. 2007;178:1418–22.
Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. Oxford University Press. 1996
Disclosure
C. O. Mmeje, A. D. Martin, R. Nunez-Nareras, and A. S. Parker reported no potential conflicts of interest relevant to this article; D. D. Thiel reported a consultancy with Myriad Genetics; and E. P. Castle reported no potential conflicts of interest relevant to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mmeje, C.O., Martin, A.D., Nunez-Nateras, R. et al. Cost Analysis of Open Radical Cystectomy Versus Robot-assisted Radical Cystectomy. Curr Urol Rep 14, 26–31 (2013). https://doi.org/10.1007/s11934-012-0292-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11934-012-0292-7